The Radboud University Medical Center and Faculty of Science announce the Radboud Consortium for Glycoscience (RCG). After the genome and proteome, the glycome offers a novel perspective to understand human disease biology. Glycoscience also plays a central role in biomass conversion, food and pharma industries. Via a 220.000 euro interfaculty grant, researchers from Radboud University will combine their multidisciplinary knowledge to develop educational programs and unclose research facilities and expertise in the field of Glycoscience.Carbohydrates are the most abundant biomolecules on earth and play a central role in biomass conversion, food and pharma industries. Glycans are composed of monosaccharides and occur ubiquitously in all organisms. Glycosylation is the process by which proteins are modified with different glycans. Although the biological language of our DNA and proteins is already well understood, this is certainly not the case for protein glycosylation. Glycoscience combines these novel fields of research and will significantly impact a broad range of research topics, ranging from evolutionary biology to food, biomass, and personalized medicine. To grasp the full potential of Glycoscience, novel technologies for their synthesis and analysis are needed.
Groups within Radboud University have strongly contributed to the international development of the field of Glycoscience with novel synthetic and biological concepts, advanced characterization methods, diagnosis and treatment of human diseases and novel functions for glycans in infectiology and oncology. A multidisciplinary approach is essential to significantly progress in this novel field. The Radboud Consortium for Glycoscience aims to advance these initiatives and to bring scientists together to stimulate new collaborations and developments in Glycoscience. The RCG will develop a teaching program on Glycoscience, will provide a platform for researchers to discuss their Glycoscience related research questions and will develop novel analytical and synthetic methodology for use in new research projects.
More information: link or send an email to: email@example.com
Related news items
Radboud-led collaboration generates innovative candidate drug against malaria19 September 2019
A molecule once designed to cure the skin disease psoriasis appears to be particularly effective against malaria. The antimalarial properties were revealed thanks to one researcher’s inspired hunch when the psoriasis drug discovery programme came to a dead end.read more
Radboud university medical center opens first healthcare AI labs19 September 2019
These are the first two ‘labs’ in the east of the Netherlands that are part of the national Innovation Center for Artificial Intelligence and the first health labs. With these two initiatives, Radboudumc and its partners are investing heavily in the application of AI to health care.read more
Careful prescription of addictive painkillers still necessary19 September 2019
Although the use of opioid painkillers in the Netherlands has risen over the past ten years, it is nowhere near the degree to which they are used in the United States, say Arnt Schellekens and his colleagues in an article published in The Lancet Public Health.read more
Exercising at home has a positive effect on Parkinson's patients19 September 2019
In a large double-blind study, Radboudumc researchers show that patients in the early stages of Parkinson's disease can exercise regularly at home for 6 months.read more
A personal touch of Kartika Hapsari18 September 2019
In order to promote interaction amongst colleagues within RIMLS, we have a ‘personal touch’ series setting employees in the spotlight. A light-hearted manner to learn about the colleagues you know and those you don’t. This week: Kartika Hapsari.read more